Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
NCT: NCT05650866 · ACTIVE_NOT_RECRUITING
Brief Summary
The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants satisfied with the device? Participants will be implanted with the device during the ongoing prostatectomy surgery and will be asked to complete the following tasks during 6 months follow-up: * Come to the hospital for follow-up visits, * Complete questionnaires, * Activate the device every day, * Measure erection hardness. Researchers will compare an implanted group (participants having the device) with a control group (participants not having the device) to see if the device works well.
Frequently Asked Questions
What is Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction?
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction is a clinical trial registered under NCT05650866. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05650866?
The current status of NCT05650866 (Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction) is: ACTIVE_NOT_RECRUITING.
When did Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction start?
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction started on 2023-05-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.